NLRP3 and cardiac hypertrophy: Low PRMT5 expression triggered the activation of the E2F-1/NF-κB signaling pathway, leading to the activation of the NLRP3 inflammasome that promotes maladaptive cardiac hypertrophy induced by transverse aortic constriction (TAC) or Ang II (104).